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Summary.-Details of sex, age at presentation and anatomical site of sarcoma com-
plicating Paget's disease of bone were recorded from the literature for white patients
in Australia, the United Kingdom and the United States over the period 1918-77.
Evidence is presented to suggest that sex and tumour-site distributions are free from
bias, except possibly for the skull. There was a male predominance for all sites
except the skull, where the odds ratio of sarcoma compared with other locations is
more than twice as high for females as for males. No national differences emerged in
the sex ratio of patients. In Australia a latitudinal effect was observed. Whereas the
percentage of males with uncomplicated Paget's disease was essentially constant,
those with sarcoma showed a decrease with increase in latitude from Queensland to
Victoria. This was attributable to tumours of the skull. Patients with bone involve-
ment above the waist were significantly younger than those with affected feet, legs
or pelvic girdle.
SARCOMAS complicating Paget's disease
of bone differ from other bone sarcomas
primarily in their later age at onset. In
England and Wales these tumours account
for more than halfofthe total bone tunmour
mortality after 60 years ofage (Boyd et al.,
1969). Price (1962) has suggested that
Paget's disease increases the risk of bone
sarcoma about 30-fold in persons over 40
years of age living in south-western
England. A recent study (Price & Jeffree,
1977) has estimated that Paget's sarcoma
constitutes 1800 of all cases of primary
sarcoma of bone in this region, making it
the second commonest type after osteo-
sarcoma of adolescents and young adults.
While the sites affected by osteo-
sarcoma with and without Paget's disease
are similar in the United States. the former
has the graver prognosis (Coley, 1960). It
invariably arises from dystrophic bone
tissue, and is characterized by a high sex
ratio and destructive malignancy, so that
few survive beyond 5 years, regardless of
the histopathology (Singer, 1977). Paget's
sarcoma appears to be less common in the
U.S.A. than in some European countries.
In the New York investigation by
McKenna et al. (1964) it accounted for
only 6% of the cases of osteosarcoma
encountered.
In Australia the frequency of sarco-
matous change in patients with Paget's
disease is thought to be less than 1%.
Unlike the tumours presenting in earlier
decades, there is no proclivity for neo-
plasia to occur at the end of the long
bones, any part of the shaft being suscep-
tible. A history of local trauma preceding
the onset ofmalignancy is elicited in about
10% of patients (Barry, 1969) although
its significance is uncertain. The same
author reported the occurrence of Paget's
sarcoma in 2 or more members of 4
families.
Publication of basic information on in-
dividual cases has continued since Paget
himself (1882, 1889) reported sarcomatous
development in some of his patients with
osteitis deformans. Because of its rarity,
international epidemiological studies have
not formerly been feasible, but numbersPAGET'S SARCOMA IN THREE COUNTRIES
are now sufficient in reports from Atisti-a
lia, Great Britain andl the United States to
make comparisonis of age at )resentation
oftumour in relation to sex ofpatients ancd
anatomical site. The restults of a statistical
analvsis for these 3 countries are describe(d
in the present study.
MIATERIALS AND METHOD)S
The nationality. sex. age at presentation
and anatomical site of sarcormia (includinig
malignlant osteoclastomna) in bone affected
with Paget's disease in whlite patients fiomn
the United Kinigdom. Australia and the
United States were recorde(d fromi the
literature. In cases wx-ith multifocal involve-
nent, the site of the first lesion to l)e recog-
nized was used. Publications became less
accessible as the reference became earlier: for
this reason- the studv was confined to material
reported in the 60-vear perio(I 1918-77.
All known cases adequately diescrilbed in
books and journals during this interval form
thie basis of the investigation. Sources of
derivation are cited in the Appendix. The
resulting distribution among countries of the
number of cases per publicationi is presented
in Table l.
In contrast to series of cases drawn from
cancer reuistries or consecutive hospital
admission records. individual patients are
frequently reported for their unusual in-
terest, such as recurrence of a malignant
osteoclastomna as a chondrosarcoma (Cones.
1953) or developmnent of lymphatic mneta-
sta,ses (Grininger & Rigler. 1968: ManeV.
1952). They are selected for a particular
feature and cannot be regarded as randomly
presented. This is truer ofsome characteristics
than others: site of tumour is inuch more
vulnerable to bias than sex of patient. In the
present study no material wN-as (drawn from
institutions treating predominantly one sex.
as in the epidemiological investigation by
Rosenkrantz et al. (1952) which was based on
admissions to a hospital for wtar veterans.
'I'he present material is therefore unlikely to
display a sex bias.
A further souIrce of variation lies in differ-
ences within and between countries i
criteria for establishing a diagnosis. Single
case presentations of sarcomas are almost
invariably histologically confirmed, and their
site and osteitis demonstrated by radiology.
This is not alwavs so for a selies of cases, in
which the age and conditioni of sotmie patienits
mayr impose limnitations. Differences iII
ascertainmenit and reporting proceduLes pre-
vent the presentationi of a uniforim schenc
indicating proportions of sarcomas diagnosed
bv various methods.
Paget's sarcoma has been reported ini non-
Caucasians on several occasions. These inl-
clude patients of Negro (Pike, 1943: Rodger
et al.. 1951), Jamaicani (Feinermani & Shapiro,
1970) and Australian aboriginal (lescent
(Barry. 1969). 'T'o avoid the confounding
effect of ethnicity these cases -were excluded.
RESULTS
It cani be shown from the distribution
in Table I that the mean number of cases
of sarcoma per publication ar-e 28 in the
Austr-alian, 5 in the British and 3 in the
American literature. To the extenit that
bias from presentation of tuntustual features
rABLE I.-Distribution anmony counitries of
cases per puiblication
PublicatiOIS
No.
cases
1
2
3
7
80
116
Total
Aulstra,lia,
I
I
Unite(l Unlite(l
Kiig(lonm States Total
14 :31 46
:3 10 13
4 6
2 3
2 .*3
2 3
1 2 3
1 1
1 1
1 1
1 1
21 56; 2
TABLE II. Distributions among couintries
of sites of sarconma
Site,
Femnur
I ^elvis
Huetru(l ls
Skutll
Tibia
Spine
Scapula
Other*
Atustralia
No. 00
:33 24
24 17
20 14
5 4
:3 2
4 :'
Total 138 100
Urnite(l
Kinlg(loru
No. 00
44 :18
18 16
21) 1 7
9) 8
11 1()
, 4
4 4
4 4
115 101
United
States
No 00
51 28
3:3 18
28 15
44 24
16 9
7 4
2 2
1 1
183 10O1
Total
No 0
128 29
88 2(1
72 17
7:3 17
:39 9
17 4
10 2
9 2
4:36 1 00
* Calcanetus, tilta, lavicle, raditts, taluts.
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is greater for reports of small numbers of
cases, the Australian site distribution
appears to be the most reliable of those
shown in Table II. Treating this as a con-
tingency table, the observed numbers of
cases were compared with those expected,
to test whether the 3 distributions were
uniform. When this was done, two of the
entries revealed a significant deviation
from expectation: a deficiency of skull
sarcoma in the U.K. and an excess in the
U.S.A.
A test of homogeneity indicated that,
when the skull was excluded, the site dis-
tributions did not vary appreciably among
the 3 countries (X2 = 1 155, 12 d.f., P > 0.4).
Pooling the data, in order to obtain a
combined estimate of the distribution,
yielded the following percentages of sarco-
matous bone involvement: femur (29)
pelvis (20), humerus (17), tibia (9), spine
(4), scapula (2) and other (2). Not a single
case affecting the fibula was reported. The
percentages for the skull were: Australia
14, the U.K. 8 and the U.S.A. 24, the
mean being 17. The unduly high percent-
age in the American series implies site bias.
This is supported by the fact that 13 of 56
papers from American journals deal solely
with skull tumours. Pooling the two
largest U.S.A. series (Schatzki & Dudley,
1961; McKenna et al., 1964) yields a pro-
portion of 8/53 or 15%. This estimate is
probably more accurate than the literature
value.
An examination of the effect of sex on
the site of tumour development revealed
that, except for the skull, malignancy
occurred more frequently in males than
females. Of 73 cases affecting the skull, 33
(450o) were males; for the remaining 363
cases involving other parts ofthe skeleton,
239 (66%) were males. The difference is
significant at the 0.100 level. Thus, the
odds ratio of a female to a male for a sar-
coma involving the skull in comparison to
other sites is 2-34, with 950o confidence
limits of 1-40 and 3-89. This finding was
consistent from country to country and is
thus unlikely to be a chance effect. Male
preponderance was greatest for malig-
nancies in the shoulder, feet, pelvis and
arms, but in no case was this significant.
A comparison showed no national
differences in the proportions of males and
females with sarcoma. In Australia the
percentage of males was 68-8 (95/138)
whilst in the U.K. it was 62 6 (72/1]15) and
in the U.S.A. 56 8 (104/183). This yielded
an overall estimate of 62-6 + 2.3% males.
There was no appreciable disparity in the
sex ratio of cases from the Bristol and
Leeds bone-tumour registries and, within
the U.S.A., the 2 largest series of patients
from Boston and New York also failed to
disclose any difference.
In Australia, numbers were sufficiently
large to compare sex ratios in 3 eastern
states: Queensland, New South Wales and
Victoria. Because of the large extent of
urbanization in these states, cases could
be assigned with a high degree ofaccuracy
to the latitudes of their 3 capital cities:
Brisbane (27°), Sydney (34°) and Mel-
bourne (380). Not only did the proportions
of the sexes differ between the cities,
but a significant effect of latitude was
discernible. In Table III the percentage of
males (corrected for the numbers of each
sex over 40 years of age) is seen to be
TABLE III. Sex distribution ofpatients with Paget's disease with and without
sarcoma in 3 eastern Australian states
UITcomplicate(d Paget's disease
_-
Paoet's sarcoma C_
State
Queensland
New South W'ales
Victoria
Total
Age-
a(ljuste(l
0 Mtales
50-1
48-4
48-1
Mtales
410
472
:1 7
1199
Females
,366
391
317
1074
Age-
a(ljLlste(l
0 Males
52'7
56-3
51.9
T'otal
776
863
634
2273
\lales
17
54
15
86
Females
4
18
17
39
Ag-
a(lj uste(l
/O Males
80-9)
76-2
48-8
Total
21
72
32
125
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TABLE IV.- Analysis of dependence ofproportion of males on latitude in
eastern Australia
Source of variationl
RegressioIn oCi latitudle
D)eviations from regression
Total
x2
6-94
2-96
9-90
All sites
(d.f. P'
1 <0-015
1 >0-08
2 <0-01
x.
6-51
0-14
6-65
Skull
(1.f. P
I <-0-02
l >0-9
2 < 0-05
Other bones
x2 (I.f. f)
2-23 1 >0-1
- 3: 1 >0-1
4-56 2 >0-1
essentially constant in patients with un-
complicated Paget's disease (Barry, 1969),
whereas those with sarcoma exhibit a
decrease from 81 to 49 with increase in
latitude from Queensland to Victoria.
The significance of the effect is demon-
strated by the analysis presented in the
first column ofTable IV. It was found that
the ratio of the coefficient of regression of
proportion of males on latitude (-0.0163)
to its standard error (0 0062) was 2 63,
which is significant at the 1% level.
Analyses shown in the 2nd and 3rd
columns of Table IV indicate that the
geographic effect is attributable to the
contribution made by sarcomas of the
skull (calvarium, mandible and maxilla).
No significant regression was found for the
remaining bones. (In Queensland, all 3
skull cases were males, 5/9 New South
Wales cases were males, and 6/7 Vic-
torians were females.) Thus the sex of
patients with sarcoma in the skull appears
to be atypical if not unique, when com-
pared with the other sites, in being prone
to latitudinal or climatic influence.
Data on the side ofthe body affected by
sarcomas other than ofthe skull, vertebrae
and sacrum were available in 201 cases of
which 94 (46 8 + 3.5%) were on the left.
No single site differed in frequency from
its expected value on the basis of equal
proportions.
To test for age-related effects, an
analysis of variance was carried out using
country, sex and site of malignancy as
factors. When site was classified according
to its location above or below the waist,
all 3 factors assumed significance. The
results of the analysis are shown in Table
V. Ages were normally distributed, vari-
ances were homogeneous and none of the
interaction. terms was significant. The
TABLE VT.-Effects of variables on age at
presentation with sarcoma (analysis of
variance)
Source of
variation
Countrv
Sex
Site
2-Way
ilnteractionls
3- WNay
interactioII
Resi(lual
Total
Slum of
squares
3547-13
636-26
422-03
d.f.
1 I
Mleani
square
1773 56
636 26
422-03
Varl-
anlce
ratio
18-20
6-53
4-33
1333-15 5 66-6:3 0-68
220-16
41318-52
46413-67
424
435
110-08 1-13
97-45
0-001
0-011
0-038
0-6:36
0(:324
greatest contributor to the mean squared
deviations was country, followed by site
and sex. The country effect was largely
due to the low age at presentation with
malignancy in the U.S.A. The mean ages
were 659 + 1 0 years for the U.K., 65-0 +
0 9 years for Australia and 59 7 + 0 7 years
for the U.S.A. With regard to sex, mean
ages were 62 3 + 0-6 years for males and
64 2 + 0 8 years for females. Finally for
site of sarcoma, the mean age was 61U6 +
0 7 years for involvement in the upper
body and 64-0 + 0 7 years in the lower
body (feet, legs and pelvic girdle).
When each country was examined
separately, the significant overall role of
site in relation to age was evident in the
U.K. but not in Australia and the U.S.A.
The age difference in the U.K. patients of
4-2 years (63.1 + 1P6 for bones above the
waist and 67-3 + 1-2 for those below the
waist) was significant at the 3%o level after
adjusting for sex. On the other hand, the
sex effect was common to each country,
females tending to present at uniformly
older ages than males. The magnitude of
the difference was 2-9 years for Australia,
1-2 vears for the U.K. and 2-7 vears for
the U.S.A.
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DISCUSSION
A not uncommon tendency towards
sarcomatous change sets Paget's disease
off from other adult dystrophic bone dis-
orders (Jaffe, 1923). The evidence pre-
sented here implies that this tendency is
subject to age, sex and geographical in-
fluences, which should contribute to a
better understanding of its epidemiology.
Bias due to selection of cases of special
interest is a hazard always present to some
degree when the material of a study is
drawn from the literature. On the grounds
that (a) large series, consisting of consecu-
tively sampled cases, constitute an appre-
ciable proportion of the data (particularly
from Australian sources), and (b) fre-
quencies of sarcoma in all sites except the
skull agree with expectation from the
observed distribution for the 3 countries
involved, it was considered that sex of
patient is a reliable variable and that
tumour site is not significantly biased. It
is not clear whether cases involving the
skull constitute an exception because of
their interest to a wider range of investi-
gators, such as neurologists, or because
their distribution actually varies geo-
graphically.
The most commonly affected areas
(femur, pelvis, humerus, skull and tibia)
indicate a proclivity for long bones
(Villiaumey & Larget-Piet, 1974). This
topography is in some respects different
from the sites most frequently attacked
by uncomplicated Paget's disease, namely
the spine, pelvis, femur and skull (Schmorl,
1932; Dickson et al., 1945; Barry, 1969;
Collins, 1956). At the other extreme, the
absence of a sarcomatous fibula is under-
standable considering the rarity of fibular
involvement with Paget's disease.
It is not surprising that the relation
between latitude and sex of patient is
undetectable in the Leeds-Bristol and
Boston-New York comparisons, since the
differences of latitude within each ofthese
pairs of cities is only 2°, whereas for
Brisbane-Melbourne it is 11°. It is note-
worthy that in Sweden, where Paget's
sarcoma is rare, the difference between the
sexes in incidence of osteogenic sarcoma
tends to diminish over a 60 increase in
latitude (Larsson & Lorentzon, 1974). The
finding that the present observation can
be attributed to geographical variation in
the sex ratio of malignancies in the skull
and facial bones, the most climatically
exposed structure of the body, suggests
that sunlight may be a factor of aetiologi-
cal importance.
For the 3 major eastern Australian
cities, latitude is highly correlated with
exposure to the sun. When the proportion
of males with sarcoma is regressed on the
number of hours of sunshine per annum
for each capital city, an outcome of
marginally greater significance than for
latitude is obtained (P= 0-01 compared
with 0-020>P>0-01). This result is
directly analogous to the sex difference in
mortality due to melanoma for the 3
corresponding states of Queensland, New
South Wales and Victoria. Beardmore
(1972) has demonstrated that when age-
standardized death rates are calculated,
the greater contribution by males dimin-
ishes the further the States are situated
from the equator.
It is therefore plausible to suggest that,
underappropriateconditions, sunlightmay
exert a carcinogenic effect on skull bones
infiltrated by Paget's disease. Grady et al.
(1943) reported amean sarcoma:carcinoma
induction ratio of 3:1 after UV irradiation
of the ears of albino mice. Nearly mono-
chromatic light of wavelength 254 nm is
only weakly carcinogenic relative to longer
wavelengths of up to 320 nm (Blum &
Lippincott, 1942). Since the intensity of
this spectrum of UV radiation is greater
(Gates, 1966) and women are more prone
to take protective measures for sunburn,
at lower than at higher latitudes, a
climatically dependent sex difference in
sarcoma induction might be anticipated.
Bloomfield (1977) has commented on
two aspects ofthe English data of Price &
Goldie (1969), namely, a right-sided pre-
ponderance of Paget's sarcoma and the
almost exclusive occurrence of pelvic
disease in males. His small Tasmanian
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series showed the same trend. However,
neither of these observations reached
significant proportions in any individual
or the combined national series.
Among the important variables asso-
ciated with the age at presentation with
sarcoma, the younger American cases
(allowing for sex) and the younger female
cases (allowing for country) are probably
due to demographic characteristics,
whereby the mean population age is lower
in the U.S.A. and women exceed men in
all 3 countries at ages at risk to contract
Paget's disease. The more interesting and
original result is the observation that, for
the combined series, after due allowance
for the effects of country and sex, patients
with affected feet, legs and pelvis present
at an average of 2-4 years later than those
whose bones are affected elsewhere.
Whether this finding is related to such
factors as walking, weight-bearing or
previous fracture remains to be elucidated.
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